v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 28,150 $ 32,275 $ 69,284 $ 61,859
General and administrative 6,949 9,070 13,823 18,527
Total operating expenses 35,099 41,345 83,107 80,386
Loss from operations (35,099) (41,345) (83,107) (80,386)
Interest income and other, net 2,190 4,391 4,808 9,363
Loss before income taxes (32,909) (36,954) (78,299) (71,023)
Income tax expense (24) (207) (74) (410)
Net loss (32,933) (37,161) (78,373) (71,433)
Other comprehensive loss        
Unrealized gain (loss) on available-for-sale investments 1 (81) (270) (196)
Comprehensive loss $ (32,932) $ (37,242) $ (78,643) $ (71,629)
Net loss per share - basic and diluted        
Net loss per share - basic $ (0.41) $ (0.44) $ (0.99) $ (0.85)
Net loss per share - diluted $ (0.41) $ (0.44) $ (0.99) $ (0.85)
Weighted-average number of common shares - basic and diluted        
Weighted-average number of common shares - basic 80,050,518 83,747,335 79,183,301 84,449,318
Weighted-average number of common shares - diluted 80,050,518 83,747,335 79,183,301 84,449,318